Literature DB >> 27547592

Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer.

D VanDyke1, P Kyriacopulos2, B Yassini1, A Wright1, E Burkhart1, S Jacek1, M Pratt1, C R Peterson1, P Rai3.   

Abstract

Treatment of cancer remains one of the most challenging tasks facing the healthcare system. Cancer affects the lives of millions of people and is often fatal. Current treatment methods include surgery, chemotherapy, radiation therapies or some combinations of these. However, recurrence is a major problem. These treatments can be invasive with severe side effects. Inefficacies in treatments are a result of the complex and variable biology of cancerous cells. Malignant tumor cells and normal functioning cells share many of the same biological characteristics but the main difference is that in cancer cells there is in an overuse and over expression of these biological characteristics. These pertinent characteristics can be grouped into eight hallmarks, as illustrated by Hanahan and Weinberg. These characteristics include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, activating invasion and metastasis, reprogramming energy metabolism, and evading immune destruction. In order to provide a noninvasive, effective treatment, delivery methods must be explored in order to transport cytotoxic agents used for targeting the hallmarks of cancer in a safer and more effective fashion. The use of nanoparticles as drug delivery carriers provides an effective method in which multiple cytotoxic agents can be safely delivered to cancer tissue to simultaneously target multiple hallmarks. By targeting multiple hallmarks of cancer at once, the efficacy of cancer treatments could be improved drastically. This review explores the uses and efficacy of combination therapies using nanoparticles that can simultaneously target multiple hallmarks of cancer.

Entities:  

Keywords:  Combination Therapy; Drug Delivery; Hybrid Nanoparticles; Nanomedicine; Oncology

Year:  2016        PMID: 27547592      PMCID: PMC4991210          DOI: 10.19070/2167-8685-SI04001

Source DB:  PubMed          Journal:  Int J Nano Stud Technol        ISSN: 2167-8685


  71 in total

1.  Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer.

Authors:  Yue Chen; Gang Wang; Deling Kong; Zhihong Zhang; Kuo Yang; Ranlu Liu; Weiming Zhao; Yong Xu
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

Review 2.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Authors:  Igor I Slowing; Juan L Vivero-Escoto; Chia-Wen Wu; Victor S-Y Lin
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

Review 3.  Nanoparticle-assisted combination therapies for effective cancer treatment.

Authors:  Che-Ming Jack Hu; Santosh Aryal; Liangfang Zhang
Journal:  Ther Deliv       Date:  2010-08

4.  Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.

Authors:  Shifalika Tangutoori; Bryan Q Spring; Zhiming Mai; Akilan Palanisami; Lawrence B Mensah; Tayyaba Hasan
Journal:  Nanomedicine       Date:  2015-09-25       Impact factor: 5.307

5.  Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model.

Authors:  R P Gude; M G Jadhav; S G A Rao; A G Jagtap
Journal:  Cancer Biother Radiopharm       Date:  2002-04       Impact factor: 3.099

6.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

7.  Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes.

Authors:  Riccardo Di Corato; Gaëlle Béalle; Jelena Kolosnjaj-Tabi; Ana Espinosa; Olivier Clément; Amanda K A Silva; Christine Ménager; Claire Wilhelm
Journal:  ACS Nano       Date:  2015-02-27       Impact factor: 15.881

8.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

Authors:  Huan Meng; Min Xue; Tian Xia; Zhaoxia Ji; Derrick Y Tarn; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2011-04-27       Impact factor: 15.881

Review 9.  Tumor-stromal cell interactions and opportunities for therapeutic intervention.

Authors:  Taturo Udagawa; Mark Wood
Journal:  Curr Opin Pharmacol       Date:  2010-07-16       Impact factor: 5.547

10.  Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.

Authors:  Na-Kyung Han; Dae Hwan Shin; Jung Seok Kim; Kwon Yeon Weon; Chang-Young Jang; Jin-Seok Kim
Journal:  Int J Nanomedicine       Date:  2016-04-05
View more
  2 in total

Review 1.  Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.

Authors:  Saeid Kargozar; Sahar Mollazadeh; Farzad Kermani; Thomas J Webster; Simin Nazarnezhad; Sepideh Hamzehlou; Francesco Baino
Journal:  J Funct Biomater       Date:  2022-07-20

2.  Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles.

Authors:  Tamoghna Mandal; Michaela Beck; Nicole Kirsten; Mika Lindén; Christian Buske
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.